1. Medtech Insight
  2. >>Digital Technologies

Digital Health Roundup, March 2021: Record-Breaking Funding; Exec Chats With Medtronic, Edwards LifeSciences

 
• By Marion Webb and Barnaby Pickering

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news to date.

Digital Health Roundup

Digital health funding hit another ground-breaking record in the first quarter of 2021, led by 25 “mega deals” that brought in more than $100m, according to digital health venture capital group Rock Health’s quarterly report. Digital funding reached $6.7bn in the first quarter, the most-funded quarter to date.

The top deals include telemedicine platform company Ro, which raised $500m in a series D round, Dispatch Health, artificial intelligence-powered drug discovery company Insitro, which pulled in $400m in a...

More from Digital Technologies

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.